Hematology. American Society of Hematology. Education ProgramHumansPurpuraThrombotic ThrombocytopenicADAMTS13 ProteinRituximab
Challenges and opportunities in the long-term management of immune-mediated TTP.
Aaron Boothby, Mouhamed Yazan Abou-Ismail, Senthil Sukumar
Published: 202510.1182/hematology.2025000758
Abstract
Diagnostic and treatment advances have revolutionized the landscape of immune-mediated thrombotic thrombocytopenic purpura (iTTP). With the widespread availability of ADAMTS13 testing and novel therapies, outcomes based primarily on platelet counts a…
Preview only. Read the full abstract at the source